Chronic Hand Eczema Guidance Highlights Diagnostic Gaps, Emerging Therapies AJMC Source link
Delgocitinib Leads to Strong 16-Week Improvement in Chronic Hand Eczema The American Journal of Managed Care® (AJMC®) Source link
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema Dermatology Times Source link
Delgocitinib Sustains Quality of Life Gains Through 52 Weeks in Chronic Hand Eczema Dermatology Times Source link